drugset / Trial / NCT07121634

Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial

NCT07121634

Active not recruiting 80 enrolled Raid M. Al-Ani
RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial compared misoprostol and isosorbide mononitrate (IMN) for cervical ripening in prolonged pregnancies. Low-risk women at 41+6 weeks gestation with an unfavorable cervix were randomized to receive either misoprostol or IMN. The primary outcome was the achievement of cervical ripeness (Bishop Score ≥6) within 40 hours.

Timeline

Start
2024-01-01
Primary completion
2025-08-20
Completion
2026-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Mononitrate Other / unclassified 40 mg Intravenous
Subject Misoprostol Other / unclassified 25 ug Intravenous

Indications